Pfizer Vaccine Safe for Children Age 5-11
Administering a 10 ug dose of the Pfizer/BioNTech COVID-19 vaccine in children age 5-11 was safe and effective, according to a Phase 2/3 trial.
Tag: vaccines
All
Latest
All
Latest
Moderna Vaccine Effective for Six Months Against Variants
The majority of individuals vaccinated with the Moderna COVID-19 vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants for six months after the second dose.
All
Latest
mRNA Vaccines Cut COVID-19 Infection Risk by 91% in Fully-Vaccinated People
People who receive mRNA COVID-19 vaccines are up to 91% less likely to develop the disease than those who are unvaccinated, according to a new nationwide study published in the NEJM.
NIH to Study Antibody Responses in Vaccinated Pregnant Women and Their Infants
The NIH has begun evaluating the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum women and their infants.
Read More
US Purchases 200 Million Additional Doses of Moderna Vaccine
The US government has purchased an additional 200 million doses of Moderna’s COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna’s pipeline.
Read More
Organ Recipients May Benefit from Three Doses of mRNA Vaccine
For the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 more than the standard two-dose regimen for people who have received solid organ transplants.
Read More
Novavax COVID-19 Vaccine 90% Effective Overall in Ph3 Trial
Novavax Inc’s COVID-19 vaccine NVX-CoV2373 demonstrated 90.4% overall efficacy against SARS-CoV-2 infection, and 100% protection against moderate and severe disease, according to a Phase 3 PREVENT-19 clinical trial.
Read More
Moderna Vaccine Submitted to FDA for EUA in Kids 12 to 17
Moderna Inc has requested an emergency use authorization for its COVID-19 vaccine in adolescents age 12 to 17 with the FDA. The vaccine has been authorized for adults age 18 and older since December 2020.
Read More
CDC: More Evidence Pfizer, Moderna Vaccines Effective Against SARS-CoV-2
A new CDC study reports the mRNA COVID-19 vaccines from Pfizer-BioNTech and Moderna reduce the risk of infection by 91% for fully vaccinated people.
Read More
NIH Begins Research into Mixed COVID-19 Booster Vaccines
An NIH Phase 1/2 clinical trial will study fully-vaccinated adult volunteers who will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
Read More
First Trial of Nanoparticle Universal Flu Vaccine Begins
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine (FluMos-v1) designed to provide long-lasting protection against multiple flu virus strains has begun at the National Institutes of Health.
Read More
Over 10,000 ‘Breakthrough’ COVID-19 Infections Reported in Fully-Vaccinated Americans
The CDC says a total of 10,262 SARS-CoV-2 vaccine breakthrough infections in fully-vaccinated Americans have been reported from 46 states and territories as of April 30, 2021.
Read More
Moderna COVID-19 Vaccine Safe, Effective in Children 12-17
A Phase 2/3 study of the Moderna COVID-19 vaccine (mRNA-1273) in adolescents age 12-17 was 93% effective and well tolerated, according to the company.
Read More
Large CDC Study of Healthcare Workers Finds COVID-19 mRNA Vaccines 94% Effective
A CDC study of 1,843 healthcare workers found that COVID-19 mRNA vaccines from Pfizer-BioNTech and Moderna reduced the risk of infection by 94% among HCWs who were fully vaccinated.
Read More
CDC Recommends Pfizer Vaccine for Children Ages 12-15
The CDC recommends all children ages 12-15 be inoculated against COVID-19 with the Pfizer/BioNTech vaccine, which was authorized for use in this population by the FDA on Monday.
Read More